Taiwan Monday, September 24, 2012, 10:00 Hrs[IST] DKSH, the leading Market Expansion Services Group with focus on Asia, and Astellas, a Japanese pharmaceutical company focusing on primary care treatments, have signed an agreement extending their partnership for medical products distribution in Taiwan market.Under the agreement, DKSH's Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, is providing logistics, physical distribution, tender management, as well as credit and collection services to Astellas for the Taiwan market."The decision to outsource logistics, distribution, and collection services for our products in the medical channel to DKSH is based on their unrivalled access to key hospitals and clinics, their commitment to quality, and their ability to provide customized and high-quality Market Expansion Services to help us grow our business in Taiwan," said Akihiro Nagaoka, president & CEO, Astellas Pharma Taiwan Inc.With the increase in counterfeit drugs being sold in the market, it is of utmost importance that medical products are managed by reliable and trusted partners. Partners who have reliable supply chain networks, and ethical business practices, backed with good compliance."This agreement is a further milestone in our regional partnership with Astellas with whom we already partner in Hong Kong, Vietnam, and Thailand. We are very pleased that they have chosen us as their partner for Taiwan and look forward to similar successes for their products in the Taiwan market," said Teresa Chen, general manager, Business Unit Healthcare, DKSH Taiwan.
No comments:
Post a Comment